ID

22382

Descrição

Study ID: 100310 Clinical Study ID: RRL100310 Study Title: A 12-week, double-blind, placebo-controlled, parallel group study to assess the efficacy and safety of intermittent dosing of ropinirole in patients with Restless Legs Syndrome (RLS) Part 2: Visit 8 (Week 15) RLS Episode 1 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00225862 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Restless Legs Syndrome More details on: https://clinicaltrials.gov/ct2/show/NCT00225862

Link

https://clinicaltrials.gov/ct2/show/NCT00225862

Palavras-chave

Versões (2)
  1. 01/06/2017 01/06/2017 -
  2. 12/06/2017 12/06/2017 -
Transferido a

1 de junho de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

  • Os mais recentes
  • Os mais antigos
  • Preferidos
  • Os mais recentes
    • Os mais recentes
    • Os mais antigos
    • Preferidos

    Sem comentários

    Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

    Intermittent Ropinirole in Restless Legs Syndrome (RLS) NCT00225862 - Part 2 Visit 8 (Week 15) RLS Episode 1

    Inglês

    Intermittent Ropinirole in Restless Legs Syndrome (RLS) NCT00225862 - Part 2 Visit 8 (Week 15) RLS Episode 1

    1 Formulários  
    General Information
    Descrição

    General Information

    Subject Identifier
    Descrição

    Subject Identifier

    Tipo de dados

    text

    PRN Subject Diary
    Descrição

    PRN Subject Diary

    1. Enter the date and time your RLs symptoms started.
    Descrição

    Date

    Tipo de dados

    datetime

    2. Severity of RLS episode
    Descrição

    Severity of RLS episode

    Tipo de dados

    text

    3. Did your RLS symptoms disrupt your routine evening activity?
    Descrição

    Did your RLS symptoms disrupt your routine evening activity?

    Tipo de dados

    boolean

    4. How severe were your RLS symptoms 2 hours after taking the study medication?
    Descrição

    Severity two hours after medication

    Tipo de dados

    text

    5. Overall, how would you describe the change in your RLS symptoms after dosing last night?
    Descrição

    Read the following and complete the questions when you wake up next morning.

    Tipo de dados

    text

    6. Overall, did your RLS symptoms affect your sleep last night?
    Descrição

    Sleep affected by RLS symptoms?

    Tipo de dados

    boolean

    If yes, did your RLS symptoms prevent you from falling asleep or staying asleep last night?
    Descrição

    Specification of RLS symptoms affecting sleep

    Tipo de dados

    boolean

    Study Medication
    Descrição

    Study Medication

    Date study medication taken
    Descrição

    Date study medication taken

    Tipo de dados

    date

    Time study medication taken
    Descrição

    Time study medication taken

    Tipo de dados

    time

    Voltar ao início da página

    Similar models

    Intermittent Ropinirole in Restless Legs Syndrome (RLS) NCT00225862 - Part 2 Visit 8 (Week 15) RLS Episode 1

    1 Formulários
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de dados
    Alias
    Item Group
    General Information
    Subject Identifier
    Item
    Subject Identifier
    text
    Item Group
    PRN Subject Diary
    Date
    Item
    1. Enter the date and time your RLs symptoms started.
    datetime
    Item
    2. Severity of RLS episode
    text
    Severity of RLS episode
    Code List
    2. Severity of RLS episode
    CL Item
    mild (1)
    CL Item
    moderate (2)
    CL Item
    severe (3)
    CL Item
    very severe (4)
    Did your RLS symptoms disrupt your routine evening activity?
    Item
    3. Did your RLS symptoms disrupt your routine evening activity?
    boolean
    Item
    4. How severe were your RLS symptoms 2 hours after taking the study medication?
    text
    Severity two hours after medication
    Code List
    4. How severe were your RLS symptoms 2 hours after taking the study medication?
    CL Item
    I was asleep at 2 hours after taking the last dose  (1)
    CL Item
    None (2)
    CL Item
    Mild (3)
    CL Item
    Moderate (4)
    CL Item
    Severe (5)
    CL Item
    Very Severe (6)
    Item
    5. Overall, how would you describe the change in your RLS symptoms after dosing last night?
    text
    Change in RLS symptoms after dosing the night before
    Code List
    5. Overall, how would you describe the change in your RLS symptoms after dosing last night?
    CL Item
    Very much improved (Complete symptom relief) (1)
    CL Item
    Much improved (Good symptom relief) (2)
    CL Item
    Minimally improved (Some symptom relief) (3)
    CL Item
    No change (4)
    CL Item
    Minimally worse (Symptoms minimally worse) (5)
    CL Item
    Much worse (Symptoms much worse) (6)
    CL Item
    Very much worse (Symptoms very much worse) (7)
    Sleep affected by RLS symptoms?
    Item
    6. Overall, did your RLS symptoms affect your sleep last night?
    boolean
    Specification of RLS symptoms affecting sleep
    Item
    If yes, did your RLS symptoms prevent you from falling asleep or staying asleep last night?
    boolean
    Item Group
    Study Medication
    Date study medication taken
    Item
    Date study medication taken
    date
    Time study medication taken
    Item
    Time study medication taken
    time
    Voltar ao início da página 

    Ajuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial